Advances in understanding respiratory syncytial virus infection in airway epithelial cells and consequential effects on the immune response

Microbes and Infection

Volumn 15, Issue 3, 2013, Pages 230-242

  Lay, Margarita K ^a   González, Pablo A ^a   León, Miguel A ^a   Céspedes, Pablo F ^a   Bueno, Susan M ^a,c   Riedel, Claudia A ^d   Kalergis, Alexis M ^a,b,c  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c INSERM   (France)

^d UNIVERSIDAD ANDRÉS BELLO   (Chile)

Author keywords

Airway epithelial cells; Entry; Immune response; Replication cycle; RSV; Thymic stromal lymphopoietin

Indexed keywords

CHOLERA TOXIN B SUBUNIT; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GANGLIOSIDE GM1; GENOMIC RNA; GLYCINE DEHYDROGENASE (DECARBOXYLATING); HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 2; RANTES; RETINOIC ACID INDUCIBLE PROTEIN I; SINGLE STRANDED RNA; THYMIC STROMAL LYMPHOPOIETIN;

BRONCHUS MUCOSA; ELECTIVE SURGERY; GENE REPLICATION; GENE SILENCING; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RNA SYNTHESIS; RNA TRANSCRIPTION; SF9 CELL; SHORT SURVEY; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS GENOME; VIRUS INCLUSION; VIRUS TRANSCRIPTION;

ANIMALS; CYTOKINES; EPITHELIAL CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; RESPIRATORY MUCOSA; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; VIRUS INTERNALIZATION; VIRUS REPLICATION;

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 84874955833     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2012.11.012     Document Type: Short Survey

References (84)

1. Robinson R.F. Impact of respiratory syncytial virus in the United States. Am. J. Health Syst. Pharm. 2008, 65:S3-S6.
2. Monto A.S. Epidemiology of viral respiratory infections. Am. J. Med. 2002, 112(Suppl. 6A):4S-12S.
3. Iwane M.K., Edwards K.M., Szilagyi P.G., Walker F.J., Griffin M.R., Weinberg G.A., Coulen C., Poehling K.A., Shone L.P., Balter S., Hall C.B., Erdman D.D., Wooten K., Schwartz B. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics 2004, 113:1758-1764.
4. Mohapatra S.S., Boyapalle S. Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma. Clin. Microbiol. Rev. 2008, 21:495-504.
5. Sigurs N., Aljassim F., Kjellman B., Robinson P.D., Sigurbergsson F., Bjarnason R., Gustafsson P.M. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax 2010, 65:1045-1052.
6. Thomsen S.F., van der Sluis S., Stensballe L.G., Posthuma D., Skytthe A., Kyvik K.O., Duffy D.L., Backer V., Bisgaard H. Exploring the association between severe respiratory syncytial virus infection and asthma: a registry-based twin study. Am. J. Respir. Crit. Care Med. 2009, 179:1091-1097.
7. Daley D., Park J.E., He J.Q., Yan J., Akhabir L., Stefanowicz D., Becker A.B., Chan-Yeung M., Bosse Y., Kozyrskyj A.L., James A.L., Musk A.W., Laprise C., Hegele R.G., Pare P.D., Sandford A.J. Associations and interactions of genetic polymorphisms in innate immunity genes with early viral infections and susceptibility to asthma and asthma-related phenotypes. J. Allergy Clin. Immunol. 2012, 10.1016/j.jaci.2012.1007.1051.
8. Stensballe L.G., Simonsen J.B., Thomsen S.F., Larsen A.M., Lysdal S.H., Aaby P., Kyvik K.O., Skytthe A., Backer V., Bisgaard H. The causal direction in the association between respiratory syncytial virus hospitalization and asthma. J. Allergy Clin. Immunol. 2009, 123. 131.e1-137.e1.
9. James K.M., Peebles R.S., Hartert T.V. Response to infections in patients with asthma and atopic disease: an epiphenomenon or reflection of host susceptibility?. J. Allergy Clin. Immunol. 2012, 130:343-351.
10. The IMpact-RSV Study Group Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998, 102:531-537.
11. Ventre K., Randolph A.G. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. Cochrane Database Syst. Rev. 2007, (1). CD000181.
12. Welliver T.P., Garofalo R.P., Hosakote Y., Hintz K.H., Avendano L., Sanchez K., Velozo L., Jafri H., Chavez-Bueno S., Ogra P.L., McKinney L., Reed J.L., Welliver R.C. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J. Infect. Dis. 2007, 195:1126-1136.
13. Aherne W., Bird T., Court S.D., Gardner P.S., McQuillin J. Pathological changes in virus infections of the lower respiratory tract in children. J. Clin. Pathol. 1970, 23:7-18.
14. Villenave R., Thavagnanam S., Sarlang S., Parker J., Douglas I., Skibinski G., Heaney L.G., McKaigue J.P., Coyle P.V., Shields M.D., Power U.F. In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:5040-5045.
15. Doherty G.M., Christie S.N., Skibinski G., Puddicombe S.M., Warke T.J., de Courcey F., Cross A.L., Lyons J.D., Ennis M., Shields M.D., Heaney L.G. Non-bronchoscopic sampling and culture of bronchial epithelial cells in children. Clin. Exp. Allergy 2003, 33:1221-1225.
16. Mink M.A., Stec D.S., Collins P.L. Nucleotide sequences of the 3' leader and 5' trailer regions of human respiratory syncytial virus genomic RNA. Virology 1991, 185:615-624.
17. McGivern D.R., Collins P.L., Fearns R. Identification of internal sequences in the 3' leader region of human respiratory syncytial virus that enhance transcription and confer replication processivity. J. Virol. 2005, 79:2449-2460.
18. Peeples M.E., Collins P.L. Mutations in the 5' trailer region of a respiratory syncytial virus minigenome which limit RNA replication to one step. J. Virol. 2000, 74:146-155.
19. Bermingham A., Collins P.L. The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:11259-11264.
20. Huang Y.T., Romito R.R., De B.P., Banerjee A.K. Characterization of the in vitro system for the synthesis of mRNA from human respiratory syncytial virus. Virology 1993, 193:862-867.
21. Collins P.L., Wertz G.W. The envelope-associated 22K protein of human respiratory syncytial virus: nucleotide sequence of the mRNA and a related polytranscript. J. Virol. 1985, 54:65-71.
22. Hardy R.W., Wertz G.W. The product of the respiratory syncytial virus M2 gene ORF1 enhances readthrough of intergenic junctions during viral transcription. J. Virol. 1998, 72:520-526.
23. Fearns R., Collins P.L. Model for polymerase access to the overlapped L gene of respiratory syncytial virus. J. Virol. 1999, 73:388-397.
24. Kuo L., Fearns R., Collins P.L. The structurally diverse intergenic regions of respiratory syncytial virus do not modulate sequential transcription by a dicistronic minigenome. J. Virol. 1996, 70:6143-6150.
25. Hanley L.L., McGivern D.R., Teng M.N., Djang R., Collins P.L., Fearns R. Roles of the respiratory syncytial virus trailer region: effects of mutations on genome production and stress granule formation. Virology 2010, 406:241-252.
26. Teng M.N., Whitehead S.S., Collins P.L. Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo. Virology 2001, 289:283-296.
27. Gan S.W., Ng L., Lin X., Gong X., Torres J. Structure and ion channel activity of the human respiratory syncytial virus (hRSV) small hydrophobic protein transmembrane domain. Protein Sci. 2008, 17:813-820.
28. Lambert D.M. Role of oligosaccharides in the structure and function of respiratory syncytial virus glycoproteins. Virology 1988, 164:458-466.
29. Tayyari F., Marchant D., Moraes T.J., Duan W., Mastrangelo P., Hegele R.G. Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat. Med. 2011, 17:1132-1135.
30. San-Juan-Vergara H., Sampayo-Escobar V., Reyes N., Cha B., Pacheco-Lugo L., Wong T., Peeples M.E., Collins P.L., Castano M.E., Mohapatra S.S. Cholesterol-rich microdomains as docking platforms for respiratory syncytial virus in normal human bronchial epithelial cells. J. Virol. 2012, 86:1832-1843.
31. Janich P., Corbeil D. GM1 and GM3 gangliosides highlight distinct lipid microdomains within the apical domain of epithelial cells. FEBS Lett. 2007, 581:1783-1787.
32. Asenjo A., Rodriguez L., Villanueva N. Determination of phosphorylated residues from human respiratory syncytial virus P protein that are dynamically dephosphorylated by cellular phosphatases: a possible role for serine 54. J. Gen. Virol. 2005, 86:1109-1120.
33. Garcia J., Garcia-Barreno B., Vivo A., Melero J.A. Cytoplasmic inclusions of respiratory syncytial virus-infected cells: formation of inclusion bodies in transfected cells that coexpress the nucleoprotein, the phosphoprotein, and the 22K protein. Virology 1993, 195:243-247.
34. Yu Q., Hardy R.W., Wertz G.W. Functional cDNA clones of the human respiratory syncytial (RS) virus N, P, and L proteins support replication of RS virus genomic RNA analogs and define minimal trans-acting requirements for RNA replication. J. Virol. 1995, 69:2412-2419.
35. Asenjo A., Calvo E., Villanueva N. Phosphorylation of human respiratory syncytial virus P protein at threonine 108 controls its interaction with the M2-1 protein in the viral RNA polymerase complex. J. Gen. Virol. 2006, 87:3637-3642.
36. Li D., Jans D.A., Bardin P.G., Meanger J., Mills J., Ghildyal R. Association of respiratory syncytial virus M protein with viral nucleocapsids is mediated by the M2-1 protein. J. Virol. 2008, 82:8863-8870.
37. Burke E., Dupuy L., Wall C., Barik S. Role of cellular actin in the gene expression and morphogenesis of human respiratory syncytial virus. Virology 1998, 252:137-148.
38. Burke E., Mahoney N.M., Almo S.C., Barik S. Profilin is required for optimal actin-dependent transcription of respiratory syncytial virus genome RNA. J. Virol. 2000, 74:669-675.
39. Brown G., Rixon H.W., Steel J., McDonald T.P., Pitt A.R., Graham S., Sugrue R.J. Evidence for an association between heat shock protein 70 and the respiratory syncytial virus polymerase complex within lipid-raft membranes during virus infection. Virology 2005, 338:69-80.
40. Radhakrishnan A., Yeo D., Brown G., Myaing M.Z., Iyer L.R., Fleck R., Tan B.H., Aitken J., Sanmun D., Tang K., Yarwood A., Brink J., Sugrue R.J. Protein analysis of purified respiratory syncytial virus particles reveals an important role for heat shock protein 90 in virus particle assembly. Mol. Cell. Proteomics 2010, 9:1829-1848.
41. Ghildyal R., Baulch-Brown C., Mills J., Meanger J. The matrix protein of human respiratory syncytial virus localises to the nucleus of infected cells and inhibits transcription. Arch. Virol. 2003, 148:1419-1429.
42. Ghildyal R., Ho A., Wagstaff K.M., Dias M.M., Barton C.L., Jans P., Bardin P., Jans D.A. Nuclear import of the respiratory syncytial virus matrix protein is mediated by importin beta1 independent of importin alpha. Biochemistry 2005, 44:12887-12895.
43. Rodriguez L., Cuesta I., Asenjo A., Villanueva N. Human respiratory syncytial virus matrix protein is an RNA-binding protein: binding properties, location and identity of the RNA contact residues. J. Gen. Virol. 2004, 85:709-719.
44. Ghildyal R., Ho A., Dias M., Soegiyono L., Bardin P.G., Tran K.C., Teng M.N., Jans D.A. The respiratory syncytial virus matrix protein possesses a Crm1-mediated nuclear export mechanism. J. Virol. 2009, 83:5353-5362.
45. Chang T.H., Segovia J., Sabbah A., Mgbemena V., Bose S. Cholesterol-rich lipid rafts are required for release of infectious human respiratory syncytial virus particles. Virology 2012, 422:205-213.
46. Fleming E.H., Kolokoltsov A.A., Davey R.A., Nichols J.E., Roberts N.J. Respiratory syncytial virus F envelope protein associates with lipid rafts without a requirement for other virus proteins. J. Virol. 2006, 80:12160-12170.
47. Shaikh F.Y., Cox R.G., Lifland A.W., Hotard A.L., Williams J.V., Moore M.L., Santangelo P.J., Crowe J.E. A critical phenylalanine residue in the respiratory syncytial virus fusion protein cytoplasmic tail mediates assembly of internal viral proteins into viral filaments and particles. MBio 2012, 3.
48. Low K.W., Tan T., Ng K., Tan B.H., Sugrue R.J. The RSV F and G glycoproteins interact to form a complex on the surface of infected cells. Biochem. Biophys. Res. Commun. 2008, 366:308-313.
49. Ghildyal R., Li D., Peroulis I., Shields B., Bardin P.G., Teng M.N., Collins P.L., Meanger J., Mills J. Interaction between the respiratory syncytial virus G glycoprotein cytoplasmic domain and the matrix protein. J. Gen. Virol. 2005, 86:1879-1884.
50. Kallewaard N.L., Bowen A.L., Crowe J.E. Cooperativity of actin and microtubule elements during replication of respiratory syncytial virus. Virology 2005, 331:73-81.
51. Utley T.J., Ducharme N.A., Varthakavi V., Shepherd B.E., Santangelo P.J., Lindquist M.E., Goldenring J.R., Crowe J.E. Respiratory syncytial virus uses a Vps4-independent budding mechanism controlled by Rab11-FIP2. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:10209-10214.
52. Baum A., Garcia-Sastre A. Induction of type I interferon by RNA viruses: cellular receptors and their substrates. Amino Acids 2010, 38:1283-1299.
53. Sha Q., Truong-Tran A.Q., Plitt J.R., Beck L.A., Schleimer R.P. Activation of airway epithelial cells by toll-like receptor agonists. Am. J. Respir. Cell. Mol. Biol. 2004, 31:358-364.
54. Pichlmair A., Schulz O., Tan C.P., Naslund T.I., Liljestrom P., Weber F., Reis e Sousa C. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 2006, 314:997-1001.
55. Rudd B.D., Burstein E., Duckett C.S., Li X., Lukacs N.W. Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. J. Virol. 2005, 79:3350-3357.
56. Bueno S.M., Gonzalez P.A., Riedel C.A., Carreno L.J., Vasquez A.E., Kalergis A.M. Local cytokine response upon respiratory syncytial virus infection. Immunol. Lett. 2011, 136:122-129.
57. Qiao J., Li A., Jin X. TSLP from RSV-stimulated rat airway epithelial cells activates myeloid dendritic cells. Immunol. Cell. Biol. 2011, 89:231-238.
58. Lee H.C., Headley M.B., Loo Y.M., Berlin A., Gale M., Debley J.S., Lukacs N.W., Ziegler S.F. Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected airway epithelial cells and promotes a type 2 response to infection. J. Allergy Clin. Immunol. 2012, 130. 1187.e5-1196.e5.
59. Xie X.H., Law H.K., Wang L.J., Li X., Yang X.Q., Liu E.M. Lipopolysaccharide induces IL-6 production in respiratory syncytial virus-infected airway epithelial cells through the toll-like receptor 4 signaling pathway. Pediatr. Res. 2009, 65:156-162.
60. Monick M.M., Yarovinsky T.O., Powers L.S., Butler N.S., Carter A.B., Gudmundsson G., Hunninghake G.W. Respiratory syncytial virus up-regulates TLR4 and sensitizes airway epithelial cells to endotoxin. J. Biol. Chem. 2003, 278:53035-53044.
61. Lukacs N.W., Smit J.J., Mukherjee S., Morris S.B., Nunez G., Lindell D.M. Respiratory virus-induced TLR7 activation controls IL-17-associated increased mucus via IL-23 regulation. J. Immunol. 2010, 185:2231-2239.
62. Spann K.M., Tran K.C., Chi B., Rabin R.L., Collins P.L. Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected]. J. Virol. 2004, 78:4363-4369.
63. Shingai M., Azuma M., Ebihara T., Sasai M., Funami K., Ayata M., Ogura H., Tsutsumi H., Matsumoto M., Seya T. Soluble G protein of respiratory syncytial virus inhibits toll-like receptor 3/4-mediated IFN-beta induction. Int. Immunol. 2008, 20:1169-1180.
64. Oshansky C.M., Krunkosky T.M., Barber J., Jones L.P., Tripp R.A. Respiratory syncytial virus proteins modulate suppressors of cytokine signaling 1 and 3 and the type I interferon response to infection by a toll-like receptor pathway. Viral Immunol. 2009, 22:147-161.
65. Kurt-Jones E.A., Popova L., Kwinn L., Haynes L.M., Jones L.P., Tripp R.A., Walsh E.E., Freeman M.W., Golenbock D.T., Anderson L.J., Finberg R.W. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 2000, 1:398-401.
66. Garofalo R., Mei F., Espejo R., Ye G., Haeberle H., Baron S., Ogra P.L., Reyes V.E. Respiratory syncytial virus infection of human respiratory epithelial cells up-regulates class I MHC expression through the induction of IFN-beta and IL-1 alpha. J. Immunol. 1996, 157:2506-2513.
67. McIntosh K. Interferon in nasal secretions from infants with viral respiratory tract infections. J. Pediatr. 1978, 93:33-36.
68. Gonzalez P.A., Bueno S.M., Carreno L.J., Riedel C.A., Kalergis A.M. Respiratory syncytial virus infection and immunity. Rev. Med. Virol. 2012, 22:230-244.
69. Gonzalez P.A., Prado C.E., Leiva E.D., Carreno L.J., Bueno S.M., Riedel C.A., Kalergis A.M. Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:14999-15004.
70. Gonzalez P.A., Bueno S.M., Riedel C.A., Kalergis A.M. Impairment of T cell immunity by the respiratory syncytial virus: targeting virulence mechanisms for therapy and prophylaxis. Curr. Med. Chem. 2009, 16:4609-4625.
71. Bueno S.M., Gonzalez P.A., Pacheco R., Leiva E.D., Cautivo K.M., Tobar H.E., Mora J.E., Prado C.E., Zuniga J.P., Jimenez J., Riedel C.A., Kalergis A.M. Host immunity during RSV pathogenesis. Int. Immunopharmacol 2008, 8:1320-1329.
72. H.C. Lee, M.B. Headley, Y.M. Loo, A. Berlin, M. Gale Jr., J.S. Debley, N.W. Lukacs, S.F. Ziegler, Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected airway epithelial cells and promotes a type 2 response to infection, J. Allergy Clin Immunol, in press.
73. Ito T., Wang Y.H., Duramad O., Hori T., Delespesse G.J., Watanabe N., Qin F.X., Yao Z., Cao W., Liu Y.J. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J. Exp. Med. 2005, 202:1213-1223.
74. Soumelis V., Reche P.A., Kanzler H., Yuan W., Edward G., Homey B., Gilliet M., Ho S., Antonenko S., Lauerma A., Smith K., Gorman D., Zurawski S., Abrams J., Menon S., McClanahan T., de Waal-Malefyt Rd R., Bazan F., Kastelein R.A., Liu Y.J. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat. Immunol. 2002, 3:673-680.
75. Lee H.C., Ziegler S.F. Inducible expression of the proallergic cytokine thymic stromal lymphopoietin in airway epithelial cells is controlled by NFκB. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:914-919.
76. Mastrangelo P., Hegele R.G. The RSV fusion receptor: not what everyone expected it to be. Microbes Infect. 2012, 14:1205-1210.
77. Crowe J.E., Bui P.T., Siber G.R., Elkins W.R., Chanock R.M., Murphy B.R. Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization. Vaccine 1995, 13:847-855.
78. Hancock G.E., Heers K.M., Pryharski K.S., Smith J.D., Tiberio L. Adjuvants recognized by toll-like receptors inhibit the induction of polarized type 2 T cell responses by natural attachment (G) protein of respiratory syncytial virus. Vaccine 2003, 21:4348-4358.
79. de Waal L., Power U.F., Yuksel S., van Amerongen G., Nguyen T.N., Niesters H.G., de Swart R.L., Osterhaus A.D. Evaluation of BBG2Na in infant macaques: specific immune responses after vaccination and RSV challenge. Vaccine 2004, 22:915-922.
80. Elliott M.B., Chen T., Terio N.B., Chong S.Y., Abdullah R., Luckay A., Egan M.A., Boutilier L.A., Melville K., Lerch R.A., Long D., Eldridge J.H., Parks C.L., Udem S.A., Hancock G.E. Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques. Vaccine 2007, 25:7132-7144.
81. Bueno S.M., Gonzalez P.A., Cautivo K.M., Mora J.E., Leiva E.D., Tobar H.E., Fennelly G.J., Eugenin E.A., Jacobs W.R., Riedel C.A., Kalergis A.M. Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:20822-20827.
82. + T cells protect against respiratory syncytial virus strain A2-Line19F-induced pathogenesis in BALB/c mice. J. Virol. 2012, 86:13016-13024.
83. Cautivo K.M., Bueno S.M., Cortes C.M., Wozniak A., Riedel C.A., Kalergis A.M. Efficient lung recruitment of respiratory syncytial virus-specific Th1 cells induced by recombinant Bacillus Calmette-Guérin promotes virus clearance and protects from infection. J. Immunol. 2010, 185:7633-7645.
84. Yokoi T., Amakawa R., Tanijiri T., Sugimoto H., Torii Y., Amuro H., Son Y., Tajima K., Liu Y.J., Ito T., Fukuhara S. Mycobacterium bovis Bacillus Calmette-Guérin suppresses inflammatory Th2 responses by inducing functional alteration of TSLP-activated dendritic cells. Int. Immunol. 2008, 20:1321-1329.